The drug “Hedroxilline” is not even being used in Kosovo for healing by COVID-19, O BSH

Laci “Hedroxilline”, which was used in Kosovo for treating patients infected with the new type of coronary (Convid-19), is currently not being used in our country either. This after the World Health Organization (OBSH) temporarily suspended its use for security causes. Infectian Salih Ahmeti tells of Kosova Prerss, that in the infectious we are not [...]
Laci “Hedroxilline”, which was used in Kosovo for treating patients infected with the new type of coronary (Convid-19), is currently not being used in our country either. This after the World Health Organization (OBSH) temporarily suspended its use for security causes.
Infectian Salih Ahmeti says of Kosova Prerss, that such a drug is not being used in the infection, and that, according to him, there is no reason.
“O The BSH has suspended it until an upcoming decision, but we've carried out the cases, and willingly and then Indigenously, that they need to use Hidroxilcolina. However, that shepherd in us was shown without any side effects and good effects. But we're at the end of the epidemic and even if we want to use it we don't have a reason”, Ahmeti declares.
This drug was used only seven days in patients, while it is said in the infectious process that no side effects have been reflects.
WHO Director Dr. Tedros Adhanom Ghebrreesesus on May 25th organised a press conference where he declared that Lancet (the medical hospital) published a survey of hydroxycollinin and chlorine effects and its effects on patients laid out by Codvis-19.
Officials report that the patient mortality rate is higher if these drugs are used alone or combined with macrolides (a type of antibiotics)”.
The medicine, announced by the President of the United States, Donald Trump, began to be used to protect against the new type of coronary, but it was reported that it increases the risk of heart disease.












